Status: current, Defined. Date: 31-Dec 2010. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2961921000168115 | Oxaliplatin (Kabi) (oxaliplatin 50 mg / 10 mL) injection, 10 mL vial (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 2961931000168117 | Oxaliplatin (Kabi) 50 mg/10 mL injection, 10 mL vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Oxaliplatin (Kabi) 50 mg/10 mL injection, 10 mL vial | has manufactured dose form | injection | true | Inferred relationship | Some | ||
| Oxaliplatin (Kabi) 50 mg/10 mL injection, 10 mL vial | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Oxaliplatin (Kabi) 50 mg/10 mL injection, 10 mL vial | Is a | Oxaliplatin (Kabi) | true | Inferred relationship | Some | ||
| Oxaliplatin (Kabi) 50 mg/10 mL injection, 10 mL vial | Is a | oxaliplatin 50 mg/10 mL injection, vial | true | Inferred relationship | Some | ||
| Oxaliplatin (Kabi) 50 mg/10 mL injection, 10 mL vial | has manufactured dose form | concentrated injection | false | Inferred relationship | Some | ||
| Oxaliplatin (Kabi) 50 mg/10 mL injection, 10 mL vial | has Australian BoSS | oxaliplatin | true | Inferred relationship | Some | 505004512 | |
| Oxaliplatin (Kabi) 50 mg/10 mL injection, 10 mL vial | has unit of use | vial | true | Inferred relationship | Some | 505004513 | |
| Oxaliplatin (Kabi) 50 mg/10 mL injection, 10 mL vial | has intended active ingredient | oxaliplatin | true | Inferred relationship | Some | 505004512 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Oxaliplatin (Kabi) 50 mg/10 mL injection, 10 mL vial | has TPUU | True | Oxaliplatin (Kabi) 50 mg/10 mL injection, 10 mL vial | Inferred relationship | Some | 1 |
| Oxaliplatin (Kabi) 50 mg/10 mL injection, 10 mL vial | has TPUU | True | Oxaliplatin (Kabi) 50 mg/10 mL injection, 10 mL vial | Inferred relationship | Some | 1 |
Reference Sets
Trade product unit of use reference set
FHIR